BIO101: Clinical Trials

1 trial of BIO101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow BIO101: new trials by email Literature Review of BIO101 trials Research Report on BIO101

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients
BIO101, Placebo - Covid-19, SARS-CoV2
Phase 2 / Phase 3TerminatedBiophytis2382020-08-262026-08-12

Conditions studied

COVID-19 (1)

Sponsors

Biophytis (1)

Countries

Belgium (1)  ·  Brazil (1)  ·  France (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Capucine Morelot-Panzini, MD (1)

Results publications

PMID 33430924, PMID 38545090